Medications for PNA and PE

Medications for Pneumonia (PNA) and Pulmonary Embolism (PE)

Medications for Pneumonia (PNA)

1. Bronchodilators
  • Purpose: Reduce bronchospasm and irritation in the lungs.

  • Types of Bronchodilators:

    • SABAs (Short-Acting Beta Agonists): Used for quick relief.

    • Examples:

      • Albuterol

      • Levalbuterol

    • Cholinergic Agonists:

    • Example: Ipatropium

  • Mechanism: Increases bronchodilation and decreases pulmonary secretions.

  • Combination Therapy: Often combined with SABA (referred to as "duoneb").

  • Considerations: Patient education on administration techniques.

2. Mucolytics and Antitussives
  • Mucolytics:

    • Purpose: For productive cough; helps thin secretions for easier expectoration.

    • Commonly Used: Guaifenesin (Mucinex).

  • Antitussives:

    • Purpose: Cough medications that suppress the cough reflex; can be beneficial for dry cough.

    • Examples:

    • Codeine/Hydrocodone

    • Dextromethorphan

    • Benzonatate (Tessalon Perles)

  • Nursing Considerations:

    • Monitor patient's cough and level of consciousness (LOC) and respiratory status when using opioids.

3. Antibiotics for Bacterial Pneumonia
  • Common Classifications:

    • Penicillins

    • Cephalosporins

  • Others: Macrolides and fluoroquinolones are used for patients with co-morbidities or previous antibiotic therapy failure.

  • Severe Cases: May require broad-spectrum antibiotics such as:

    • Piperacillin/tazobactam

    • Vancomycin (for drug-resistant strains)

  • Nursing Protocols:

    • It's essential to obtain cultures before starting antibiotic therapy.

    • Transition patients from IV to oral antibiotics as soon as feasible.

    • Educate patients about potential side effects and the importance of completing the prescribed full course of antibiotics.

    • If no improvement is noted, patients should contact their healthcare provider.

4. Anti-Inflammatories
  • Purpose: Glucocorticoids used to reduce inflammation associated with pneumonia.

  • Examples:

    • Fluticasone

    • Prednisone

  • Administration Protocol: Start with IV and transition to oral as the patient's condition stabilizes.

  • Patient Education: Important details about the administration of these medications to ensure effectiveness.

Medications for Pulmonary Embolism (PE)

1. Anticoagulants
  • Critical Need for Immediate Anticoagulation: Required unless there are contraindications.

  • Types:

    • Unfractionated Heparin: Administered as a continuous drip.

    • Low-Molecular-Weight Heparin: Given as subcutaneous injections (SQ) such as Enoxaparin.

    • Warfarin: Oral anticoagulant used for long-term management.

  • Nursing Considerations:

    • Monitor bleeding times according to hospital protocols.

    • Watch for signs and symptoms of bleeding during therapy, such as unusual bruising or blood in urine/stools.

    • Educate patients about long-term therapy expectations.

    • Discuss the route of administration, dietary considerations while on anticoagulants, and safety precautions to prevent bleeding.

2. Direct Factor Xa Inhibitors
  • Function: Inhibit thrombin production.

  • Usage: Used typically as a “bridge” from other anticoagulation therapies.

  • Examples:

    • Rivaroxaban

    • Apixaban

  • Nursing Duties:

    • Assess for signs and symptoms of bleeding.

    • Monitor bleeding times as per protocol.

    • Provide education about long-term therapy and safety measures.

3. Thrombolytic Therapy
  • Purpose: Used to dissolve blood clots and restore normal circulation.

  • Contraindications: Share similarities with anticoagulation therapy.

  • Examples:

    • Alteplase (Activase)

    • tPA

4. Medication Administration Summary

Drug

Route of Administration

Considerations

Warfarin (Coumadin)

PO

Monitor INR; give at the same time daily; antidote: Vitamin K

Low-Molecular Weight Heparin

Subcutaneous

Routine tests not needed; monitor CBC; reduce dose in renal impairment; antidote: Protamine

Unfractionated Heparin

IV

Monitor aPTT; monitor CBC; antidote: Protamine

Factor Xa Inhibitors

PO

Approved for VTE; monitor CBC and kidney function; may cause thrombocytopenia; antidote: andexanet alfa